Retour
Ascentage Pharma Group International (ASPHF) Gagner
Graphique du cours de l'action ASPHF
ASPHF Gagner
Ascentage Pharma Group International
$8.48
0%
$0
À la fermeture : Mar 24, 16:00:00 GMT-4
$8.48
0%
$0
Post-Marché: Mar 24, 16:35:14 GMT-4
Statistiques clés
Clôture préc.
$8.48
Prix d'ouverture
$8.48
Plage de la journée
$8.48 - $8.48
Plage de 52 semaines
$5.82 - $10.65
Volume
100
Volume moyen
59
Rendement en dividend
--
BPA (TTM)
-0.52
Capitalisation boursière
$788.3M
Qu’est-ce que ASCENTAGE PHARMA GROUP INTL ?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.